Dra. Teraiza Mesa R.,
Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose https://www.ncbi.nlm.ni…
Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose https://www.ncbi.nlm.ni…
Recent reports showed that cannabidiol alleviated the signs and symptoms of schizophrenia.
Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose. https://www.ncbi.nlm.n…